• Je něco špatně v tomto záznamu ?

Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors

J. Smahelova, B. Pokryvkova, E. Stovickova, M. Grega, O. Vencalek, M. Smahel, V. Koucky, S. Malerova, J. Klozar, R. Tachezy

. 2024 ; 19 (1) : 26. [pub] 20240610

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24012571

Grantová podpora
Inter-Excellence programme (No. LTAUSA18003) Ministry of Education, Youth and Sports, Czech Republic
Programme EXCELES, ID Project No. LX22NPO5103 European Union - Next Generation EU
SVV260679 Charles University, Prague, Czech Republic

BACKGROUND: A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors. METHODS: In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry. RESULTS: Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status. CONCLUSION: The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012571
003      
CZ-PrNML
005      
20240726151403.0
007      
ta
008      
240723s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13027-024-00588-1 $2 doi
035    __
$a (PubMed)38858774
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Smahelova, Jana $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
245    10
$a Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors / $c J. Smahelova, B. Pokryvkova, E. Stovickova, M. Grega, O. Vencalek, M. Smahel, V. Koucky, S. Malerova, J. Klozar, R. Tachezy
520    9_
$a BACKGROUND: A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors. METHODS: In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry. RESULTS: Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status. CONCLUSION: The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pokryvkova, Barbora $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
700    1_
$a Stovickova, Eliska $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
700    1_
$a Grega, Marek $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Vencalek, Ondrej $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Smahel, Michal $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
700    1_
$a Koucky, Vladimir $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Malerova, Simona $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Klozar, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic. tachezr@natur.cuni.cz
773    0_
$w MED00165433 $t Infectious agents and cancer $x 1750-9378 $g Roč. 19, č. 1 (2024), s. 26
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38858774 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151356 $b ABA008
999    __
$a ok $b bmc $g 2125409 $s 1224434
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 19 $c 1 $d 26 $e 20240610 $i 1750-9378 $m Infectious agents and cancer $n Infect Agent Cancer $x MED00165433
GRA    __
$a Inter-Excellence programme (No. LTAUSA18003) $p Ministry of Education, Youth and Sports, Czech Republic
GRA    __
$a Programme EXCELES, ID Project No. LX22NPO5103 $p European Union - Next Generation EU
GRA    __
$a SVV260679 $p Charles University, Prague, Czech Republic
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...